Skip to main content
. 2016 Dec 15;13(2):614–618. doi: 10.3892/etm.2016.3974

Figure 1.

Figure 1.

Figure 1.

(A) Tail intensity and (B) telomerase activity (%) of stanozolol and propylene glycol (PG)-exposed groups. Group I, control; group II, PG; group III, stanozolol; group IV, PG treatment and exercise; group V, stanozolol treatment and exercise. Extreme outliers are indicated by an asterisk (*) and circle (º).